Cord blood infusions aim to slow Alzheimer's decline

NCT ID NCT07208344

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether infusions of cells from umbilical cord blood can help people with mild to moderate Alzheimer's disease. Thirty participants will receive either a low dose, high dose, or a placebo (salt water) through an IV once a week for four weeks, plus a fifth dose a month later. Researchers will track changes in thinking, daily living skills, and blood markers over six months to see if the treatment is safe and effective.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of the University of Science and Technology of China

    RECRUITING

    Hefei, Anhui, 230000, China